SARS-CoV-2 and Pregnancy: A Review of the Facts.
Ricardo Mamber CzeresniaAyssa Teles Abrao TradIngrid Schwach Werneck BrittoRomulo NegriniMarcelo Luís NomuraPedro Pires Ferreira NetoFabrício da Silva CostaRoseli Mieko Yamamoto NomuraRodrigo RuanoPublished in: Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia (2020)
The COVID-19 outbreak resulted in a pandemic with > 3.3 million cases and 230 thousand deaths until May 2nd. It is caused by the SARS-CoV2 virus and may lead to severe pulmonary infection and multi-organ failure. Past experiences show that unique characteristics in pregnancy make pregnant women more susceptible to complications from viral infections. Yet, this has not been reported with this new virus. There are risk factors that seem to increase morbidity in pregnancy, such as obesity (body mass index [BMI] > 35), asthma and cardiovascular disease. Current reports describe an increased rate of preterm birth and C-section. Vertical transmission is still a possibility, due to a few reported cases of neonatal positive real-time polymerase chain reaction (RT-PCR) in nasal swab, amniotic fluid, and positive immunoglobulin M (IgM) in neonatal blood. Treatments must be weighed in with caution due to the lack of quality trials that prove their effectiveness and safety during pregnancy. Medical staff must use personal protective equipment in handling SARS-CoV2 suspected or positive patients and be alert for respiratory decompensations.
Keyphrases
- sars cov
- preterm birth
- body mass index
- risk factors
- pregnant women
- low birth weight
- respiratory syndrome coronavirus
- cardiovascular disease
- gestational age
- weight gain
- end stage renal disease
- pregnancy outcomes
- type diabetes
- healthcare
- ejection fraction
- newly diagnosed
- metabolic syndrome
- chronic kidney disease
- peritoneal dialysis
- insulin resistance
- chronic obstructive pulmonary disease
- weight loss
- mental health
- prognostic factors
- pulmonary embolism
- early onset
- quality improvement
- bone marrow
- coronavirus disease
- patient reported outcomes
- physical activity
- coronary artery disease
- skeletal muscle
- mesenchymal stem cells
- umbilical cord
- respiratory tract